74 related articles for article (PubMed ID: 17894417)
21. Nitroreductase from Bacillus licheniformis: a stable enzyme for prodrug activation.
Emptage CD; Knox RJ; Danson MJ; Hough DW
Biochem Pharmacol; 2009 Jan; 77(1):21-9. PubMed ID: 18840409
[TBL] [Abstract][Full Text] [Related]
22. Membrane protease degradomics: proteomic identification and quantification of cell surface protease substrates.
Butler GS; Dean RA; Smith D; Overall CM
Methods Mol Biol; 2009; 528():159-76. PubMed ID: 19153692
[TBL] [Abstract][Full Text] [Related]
23. SPOT synthesis of peptide arrays on self-assembled monolayers and their evaluation as enzyme substrates.
Laurent N; Haddoub R; Voglmeir J; Wong SC; Gaskell SJ; Flitsch SL
Chembiochem; 2008 Nov; 9(16):2592-6. PubMed ID: 18821537
[No Abstract] [Full Text] [Related]
24. Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis.
Gabriel D; Busso N; So A; van den Bergh H; Gurny R; Lange N
J Control Release; 2009 Sep; 138(3):225-34. PubMed ID: 19445983
[TBL] [Abstract][Full Text] [Related]
25. Enzymatic digestion and chromatographic analysis of arsenic species released from proteins.
Lu M; Wang H; Li XF; Lu X; Le XC
J Chromatogr A; 2009 May; 1216(18):3985-91. PubMed ID: 19327778
[TBL] [Abstract][Full Text] [Related]
26. "Reverse degradomics", monitoring of proteolytic trimming by multi-CE and confocal detection of fluorescent substrates and reaction products.
Piccard H; Hu J; Fiten P; Proost P; Martens E; Van den Steen PE; Van Damme J; Opdenakker G
Electrophoresis; 2009 Jul; 30(13):2366-77. PubMed ID: 19621364
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial activity and protease stability of peptides containing fluorinated amino acids.
Meng H; Kumar K
J Am Chem Soc; 2007 Dec; 129(50):15615-22. PubMed ID: 18041836
[TBL] [Abstract][Full Text] [Related]
28. [Research of oral prodrugs: opportunities and challenges].
Cao F; Ping QN; Chen J
Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
[TBL] [Abstract][Full Text] [Related]
29. Mass spectrometric identification of formaldehyde-induced peptide modifications under in vivo protein cross-linking conditions.
Toews J; Rogalski JC; Clark TJ; Kast J
Anal Chim Acta; 2008 Jun; 618(2):168-83. PubMed ID: 18513538
[TBL] [Abstract][Full Text] [Related]
30. The role of proteases in pathologies of the synovial joint.
Jones GC; Riley GP; Buttle DJ
Int J Biochem Cell Biol; 2008; 40(6-7):1199-218. PubMed ID: 18339575
[TBL] [Abstract][Full Text] [Related]
31. In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach.
Varghese OP; Sun W; Hilborn J; Ossipov DA
J Am Chem Soc; 2009 Jul; 131(25):8781-3. PubMed ID: 19499915
[TBL] [Abstract][Full Text] [Related]
32. Testing double mutants of the enzyme nitroreductase for enhanced cell sensitisation to prodrugs: effects of combining beneficial single mutations.
Jaberipour M; Vass SO; Guise CP; Grove JI; Knox RJ; Hu L; Hyde EI; Searle PF
Biochem Pharmacol; 2010 Jan; 79(2):102-11. PubMed ID: 19665450
[TBL] [Abstract][Full Text] [Related]
33. Image-guided enzyme/prodrug cancer therapy.
Li C; Penet MF; Winnard P; Artemov D; Bhujwalla ZM
Clin Cancer Res; 2008 Jan; 14(2):515-22. PubMed ID: 18223227
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of glutathione peptidomimetics as components of anti-Parkinson prodrugs.
More SS; Vince R
J Med Chem; 2008 Aug; 51(15):4581-8. PubMed ID: 18651729
[TBL] [Abstract][Full Text] [Related]
35. Functional ubiquitin conjugates with lysine-epsilon-amino-specific linkage by thioether ligation of cysteinyl-ubiquitin peptide building blocks.
Jung JE; Wollscheid HP; Marquardt A; Manea M; Scheffner M; Przybylski M
Bioconjug Chem; 2009 Jun; 20(6):1152-62. PubMed ID: 19469549
[TBL] [Abstract][Full Text] [Related]
36. Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters.
Lin YS; Tungpradit R; Sinchaikul S; An FM; Liu DZ; Phutrakul S; Chen ST
J Med Chem; 2008 Dec; 51(23):7428-41. PubMed ID: 19053781
[TBL] [Abstract][Full Text] [Related]
37. Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy.
Friedlos F; Lehouritis P; Ogilvie L; Hedley D; Davies L; Bermudes D; King I; Martin J; Marais R; Springer CJ
Clin Cancer Res; 2008 Jul; 14(13):4259-66. PubMed ID: 18594008
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase-assisted triggered release of liposomal contents.
Sarkar N; Banerjee J; Hanson AJ; Elegbede AI; Rosendahl T; Krueger AB; Banerjee AL; Tobwala S; Wang R; Lu X; Mallik S; Srivastava DK
Bioconjug Chem; 2008 Jan; 19(1):57-64. PubMed ID: 18078309
[TBL] [Abstract][Full Text] [Related]
39. Drug delivery by an enzyme-mediated cyclization of a lipid prodrug with unique bilayer-formation properties.
Linderoth L; Peters GH; Madsen R; Andresen TL
Angew Chem Int Ed Engl; 2009; 48(10):1823-6. PubMed ID: 19173369
[TBL] [Abstract][Full Text] [Related]
40. Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning library.
Schmid B; Warnecke A; Fichtner I; Jung M; Kratz F
Bioconjug Chem; 2007; 18(6):1786-99. PubMed ID: 17915955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
